SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001701541-24-000009
Filing Date
2024-03-12
Accepted
2024-03-12 07:17:49
Documents
16
Period of Report
2024-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdtx-20240312.htm   iXBRL 8-K 26958
2 EX-99.1 bdtx-exhibit991_q42023.htm EX-99.1 62769
6 GRAPHIC logo.jpg GRAPHIC 14262
  Complete submission text file 0001701541-24-000009.txt   239829

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20240312.xsd EX-101.SCH 1952
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20240312_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20240312_pre.xml EX-101.PRE 13077
17 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20240312_htm.xml XML 2833
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 24740178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)